Low Risk Myelodysplastic Syndromes Not Yet Recruiting Phase 2 Trials for SEL120-34A free base (DB18107)

Also known as: Low Risk Myelodysplastic Syndrome / Low-risk Myelodysplastic Syndrome

IndicationStatusPhase
DBCOND0147387 (Low Risk Myelodysplastic Syndromes)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06243458RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic NeoplasmsTreatment